Advanced glycation end products (AGE) and their receptor (RAGE) in the brain of patients with Creutzfeldt-Jakob disease with prion plaques.
- 1 June 2002
- journal article
- research article
- Published by Elsevier in Neuroscience Letters
- Vol. 326 (2) , 117-120
- https://doi.org/10.1016/s0304-3940(02)00310-5
Abstract
No abstract availableKeywords
This publication has 14 references indexed in Scilit:
- Neurodegenerative Diseases and PrionsNew England Journal of Medicine, 2001
- Advanced Glycation End Products in Alzheimer's Disease and Other Neurodegenerative DiseasesThe American Journal of Pathology, 1998
- What's the RAGE? The receptor for advanced glycation end products (RAGE) and the dark side of glucoseEuropean Journal of Clinical Investigation, 1997
- Scavenger receptor-mediated adhesion of microglia to β-amyloid fibrilsNature, 1996
- RAGE and amyloid-β peptide neurotoxicity in Alzheimer's diseaseNature, 1996
- 'Toxicity of glucose: is AGE the answer?'Nephrology Dialysis Transplantation, 1995
- Advanced Maillard reaction end products are associated with Alzheimer disease pathology.Proceedings of the National Academy of Sciences, 1994
- Molecular Cloning of a Human Prion Protein cDNADNA, 1986
- Nonenzymatic Glycosylation and the Pathogenesis of Diabetic ComplicationsAnnals of Internal Medicine, 1984
- Nonenzymatic Browning in Vivo: Possible Process for Aging of Long-Lived ProteinsScience, 1981